SARS-CoV-2 vaccine clinical efficacy in SOT: What we know and our current gaps
Transpl Infect Dis
.
2022 Apr;24(2):e13809.
doi: 10.1111/tid.13809.
Epub 2022 Feb 25.
Authors
Rachel Sigler
1
,
Saima Aslam
1
Affiliation
1
Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, California, USA.
PMID:
35148028
PMCID:
PMC9019848
DOI:
10.1111/tid.13809
No abstract available
Publication types
Editorial
MeSH terms
COVID-19 Vaccines*
COVID-19* / prevention & control
Humans
SARS-CoV-2
Transplant Recipients
Treatment Outcome
Substances
COVID-19 Vaccines
Grants and funding
UL1 TR001442/TR/NCATS NIH HHS/United States
UL1TR001442 to SA/TR/NCATS NIH HHS/United States